Skip to main content

Table 3 Baseline characteristics, morbidities, complications, outcomes of influenza infection cases treat with or without oseltamivir, 2013-2015

From: Risk of mortality associated with respiratory syncytial virus and influenza infection in adults

Variables Influenza not treated with Oseltamivir (N = 65) Influenza treated with Oseltamivir (N = 247) P value
Male, n (%) 30 (46.2) 123 (49.8) 0.60
Age (years) mean (SD) 61.2 (18.3) 63.0 (16.7) 0.44
Resident of long-term care facilities, n (%) 1 (1.5) 5 (2.0) 0.80
Malignancy, n (%) 6 (9.2) 26 (10.5) 0.08
Congestive heart failure, n (%) 8 (12.3) 15 (6.1) 0.08
Cerebrovascular accident, n (%) 4 (6.2) 35 (14.2) 0.08
Chronic kidney disease, n (%) 8 (12.3) 30 (12.1) 0.91
Diabetes, n (%) 23 (35.4) 57 (23.1) 0.04
Liver disease, n (%) 5 (7.7) 20 (8.1) 0.91
Chronic obstructive pulmonary disease, n (%) 6 (9.2) 9 (3.6) 0.06
Asthma, n (%) 6 (9.2) 14 (5.7) 0.29
Body temperature > 37.5 °C, n (%) 17 (26.2) 93 (37.7) 0.08
Pneumonia, n (%) 19 (29.2) 59 (23.9) 0.37
Respiratory bacterial superinfection, n (%) 6 (9.2) 26 (10.5) 0.76
Hypoxemia, n (%) 17 (26.2) 76 (30.8) 0.47
Mechanical ventilation, n (%) 3 (4.6) 4 (1.6) 0.14
PSI score, mean (SD) 85.0 (36.6) 86.9 (34.5) 0.70
Twenty-day all-cause mortality (%) 5 (7.7) 16 (6.5) 0.72
Sixty-day all-cause mortality (%) 12 (18.5) 26 (10.5) 0.09
  1. PSI pneumonia severity index, SD standard deviation
  2. PSI was calculated in all patients with or without pneumonia